BDSX - CIK 0001439725
BIODESIX INC (BDSX) reported net income of -$35.27M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$35.27M | +17.8% |
| FY 2024 | -$42.93M | +17.7% |
| FY 2023 | -$52.15M | +20.3% |
| FY 2022 | -$65.45M | -51.6% |
| FY 2021 | -$43.16M | +34.1% |
| FY 2020 | -$65.45M | -113.0% |
| FY 2019 | -$30.73M | - |
BIODESIX INC (BDSX) reported net income of -$35.27M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, BIODESIX INC's net income declined from -$30.73M to -$35.27M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.